Unbiased AI-powered news
A Paris court ruled that TotalEnergies must account for emissions from its customers under France's Corporate Duty of Vigilance law. The decision marks the first application of the statute to climate-related obligations.
France 24A French court has ordered TotalEnergies to include emissions generated by its clients when preparing the company's climate plan. The ruling applies France's Corporate Duty of Vigilance law to climate change for the first time.
The court directed the energy company to revise its existing climate strategy to cover downstream emissions from product use. Judges found that the current plan did not meet the requirements of the 2017 vigilance statute. The company must now submit an updated plan that addresses these emissions within a court-specified timeframe.
Vigilance law requires large French companies to identify and prevent human-rights and environmental risks linked to their operations. Prior cases under the statute focused on supply-chain labor issues rather than greenhouse-gas accounting. The new decision broadens the law's scope to encompass climate impacts tied to customer activities.
TotalEnergies stated it is reviewing the judgment and will determine next steps after internal assessment. The company did not indicate whether it plans to appeal. No timeline for compliance has been released by the court.
Los Angeles TimesThe Defense Department reinstated required flu vaccinations for new recruits after an outbreak at Lackland Air Force Base sickened nearly 300 people. The reversal ends a policy that had made the shots optional for the first time in 70 years.
upi.comSens. Kirsten Gillibrand and Eric Schmitt urged Defense Secretary Peter Hegseth to remove rules limiting Applied Behavior Analysis therapy under TRICARE. The letter followed an NBC News report detailing coverage denials for military families. It seeks to designate the therapy as…
upi.comThe legislation would let drugmakers issue retroactive rebates and impose new rules on hospitals and contract pharmacies. Separately, the Trump administration is considering Jeff Vacirca to lead the FDA.